Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 2
1996 5
1997 8
1998 8
1999 15
2000 22
2001 24
2002 15
2003 20
2004 22
2005 28
2006 12
2007 21
2008 17
2009 24
2010 31
2011 27
2012 23
2013 32
2014 19
2015 21
2016 19
2017 34
2018 21
2019 24
2020 28
2021 40
2022 33
2023 27
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

585 results

Results by year

Filters applied: . Clear all
Page 1
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.
Kotton CN, Torre-Cisneros J; International CMV Symposium Faculty; Aguado JM, Alain S, Baldanti F, Baumann G, Boeken U, de la Calle M, Carbone J, Ciceri F, Comoli P, Couzi L, Danziger-Isakov L, Fernández-Ruiz M, Girmenia C, Grossi PA, Hirsch HH, Humar A, Kamar N, Kotton C, Ljungman P, Malagola M, Mira E, Mueller N, Sester M, Teng CJ, Torre-Cisneros J, Ussetti P, Westall G, Wolf D, Zamora M. Kotton CN, et al. Among authors: humar a. Transpl Infect Dis. 2022 Dec;24(6):e13977. doi: 10.1111/tid.13977. Epub 2022 Nov 11. Transpl Infect Dis. 2022. PMID: 36271650 Free PMC article. Review.
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients.
Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, Sgarabotto D, Tuncer M, Noronha IL, Hartmann A; VICTOR Study Group. Asberg A, et al. Among authors: humar a. Am J Transplant. 2007 Sep;7(9):2106-13. doi: 10.1111/j.1600-6143.2007.01910.x. Epub 2007 Jul 19. Am J Transplant. 2007. PMID: 17640310 Free article. Clinical Trial.
Liver transplantation: current and future.
Hughes CB, Humar A. Hughes CB, et al. Among authors: humar a. Abdom Radiol (NY). 2021 Jan;46(1):2-8. doi: 10.1007/s00261-019-02357-w. Abdom Radiol (NY). 2021. PMID: 31953588 Review.
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
Tran BV, Moris D, Markovic D, Zaribafzadeh H, Henao R, Lai Q, Florman SS, Tabrizian P, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Hoteit M, Levine MH, Cillo U, Vitale A, Verna EC, Halazun KJ, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo F, Lerut J, Ciccarelli O, Nguyen MH, Melcher ML, Viveiros A, Schaefer B, Hoppe-Lotichius M, Mittler J, Nydam TL, Markmann JF, Rossi M, Mobley C, Ghobrial M, Langnas AN, Carney CA, Berumen J, Schnickel GT, Sudan DL, Hong JC, Rana A, Jones CM, Fishbein TM, Busuttil RW, Barbas AS, Agopian VG. Tran BV, et al. Among authors: humar a. Liver Transpl. 2023 Jul 1;29(7):683-697. doi: 10.1097/LVT.0000000000000145. Epub 2023 Apr 10. Liver Transpl. 2023. PMID: 37029083
CMV immune monitoring-Where do we go from here?
Kumar D, Humar A. Kumar D, et al. Among authors: humar a. Am J Transplant. 2020 Aug;20(8):1961-1962. doi: 10.1111/ajt.15875. Epub 2020 Apr 15. Am J Transplant. 2020. PMID: 32216014 Free article. No abstract available.
Pancreas donors.
Humar A. Humar A. Curr Opin Organ Transplant. 2007 Feb;12(1):73-76. doi: 10.1097/MOT.0b013e328012dd88. Curr Opin Organ Transplant. 2007. PMID: 27792093
585 results